10-Mar-2014 - Publication of a US FDA enforcement report detailing a recall conducted by Ranbaxy in January saw the beleaguered Indian drugmakers’ share price fall 3% last week.
10-Mar-2014 - Drug excipient makers in India and those serving the market have a dedicated IPEC chapter after the delayed fifth branch of the industry group was finally formally incorporated at the end of January.
03-Mar-2014 - Criminal access to APIs must be cut off in a way that does not infringe generics companies’ right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
27-Feb-2014 - BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
26-Feb-2014 - Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
25-Feb-2014 - FMC has hired Connell Brothers (CBC) to distribute its drug excipients in Japan, citing the move as a key step to building its business in the country.
25-Feb-2014 - Ranbaxy has temporarily halted all shipments from two API plants currently under a US FDA consent decree, although both the firm and an analyst say a shortage is unlikely.
20-Feb-2014 - Four more drug excipient suppliers have been certified under the newly independent Excipact quality scheme.
17-Feb-2014 - AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
17-Feb-2014 - Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and margin growth in 2014.
13-Feb-2014 - A US attorney who worked with Pfizer, Lilly and Merck to jail drug counterfeiters says cutting off criminal access to active pharmaceutical ingredients (APIs) is key.
13-Feb-2014 - A Hong Kong API distributor has received a Warning Letter from the US FDA after failing to have a Quality Unit and incorrectly labelling products.
11-Feb-2014 - The team behind the scheme that helped BASF, Seppic and Merck KGaA reduce their audit burdens expect more excipient suppliers to seek certification as an independent association.
11-Feb-2014 - NSF International has acquired the auditing subsidiary of the International Pharmaceutical Excipients Council of the Americas (IPEC) as part of a way to ensure a more streamlined supplier qualification process.
06-Feb-2014 - Jubilant Life Sciences has dismissed claims it is looking to sell off its fine chemicals business.
04-Feb-2014 - CRO Ergomed Clinical Research has partnered with Ferrer to support a Phase IIa study of the insomnia drug Lorediplon.
04-Feb-2014 - Novozymes Biopharma has confirmed that two “top 10” pharmaceutical firms are using its modified human albumin in their drug development programmes.
04-Feb-2014 - Johnson Matthey's decision to restructure its narcotic API business in light of increased UK competition has paid off, the company says.
30-Jan-2014 - Increasing demand for HPAPIs has driven Patheon to invest in its Milton Park, UK manufacturing facility, the company says.
29-Jan-2014 - Northwest Biotherapeutics has agreed with CMO Cognate Bioservices to begin a large-scale expansion of the manufacturing, storage, handling and distribution of its personalized immune therapies for solid tumor cancers.
27-Jan-2014 - Daiichi-Sankyo says ensuring API supply could be a problem at Ranbaxy’s US finished product sites after imports are banned from yet another of its Indian facilities.
27-Jan-2014 - A French subsidiary of specialty ingredients firm Seppic has become the latest supplier certified under the Excipact quality scheme for drug excipients
23-Jan-2014 - Increased in-house API production and manufacturing in India will lower the costs of Hospira’s injectables, the firm says, as it looks past current remediation efforts.
23-Jan-2014 - Higher earnings and improved margins did not impress investors in Lonza, which saw its share price tumble today after revealing that sales to the drug sector fell in 2013.
21-Jan-2014 - European dependence on drugs and APIs made outside the EU is still ‘alarming’ despite recently introduced anti-falsified meds laws according to the European Fine Chemicals Group (EFCG).
A longer than expected upgrade to one of its injectable plants has caused Pfizer to announce that...
Despite splintering into rival companies a century ago, Merck & Co. and Merck KGaA have once again...
Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and...
The US FDA has upgraded Hospira’s troubled Rocky Mount, North Carolina plant to VAI (voluntary action indicated)...
It is too early to predict what impact proposed changes to US rules on chemical plant security...
Pfizer says its ‘off the shelf’ aseptic processing capacity is shifting the paradigm of pharma manufacturing, with...